{"id":75190,"date":"2021-01-04T15:17:57","date_gmt":"2021-01-04T09:47:57","guid":{"rendered":"https:\/\/blog.forumias.com\/?p=75190"},"modified":"2021-01-04T16:29:45","modified_gmt":"2021-01-04T10:59:45","slug":"expert-panel-grants-emergency-use-authorisation-for-oxford-vaccine","status":"publish","type":"post","link":"https:\/\/forumias.com\/blog\/expert-panel-grants-emergency-use-authorisation-for-oxford-vaccine\/","title":{"rendered":"Expert panel grants emergency use authorisation for Oxford vaccine"},"content":{"rendered":"<p><strong>News:<\/strong>\u00a0The subject expert committee of Central Drugs Standard Control Organization(CDSCO) has recommended COVID-19 vaccine, Covishield for emergency use authorisation.<\/p>\n<p><strong>Facts:<\/strong><\/p>\n<ul>\n<li><strong>COVISHIELD:\u00a0<\/strong>The Oxford vaccine \u201cAZD1222\u201d is being called Covishield in India. Serum Institute of India(SII) has entered into a manufacturing partnership with Oxford University and Pharma major AstraZeneca to produce this vaccine in India.<\/li>\n<li><strong>Technology<\/strong>: Covishield is made of a weakened and modified version of adenovirus (a common cold virus) that causes infections in chimpanzees and contains the genetic material of the SARS-CoV-2 virus spike protein. After vaccination, the surface spike protein is produced, priming the immune system to attack the SARS-CoV-2 virus if it later infects the body.<\/li>\n<li><strong>Efficacy:\u00a0<\/strong>Researchers claimed the vaccine protected against Covid in 62% of those given two full doses and in 90% of those initially given a half dose.<\/li>\n<li><strong>Safety<\/strong>: The Lancet publication, a leading medical journal has confirmed that the vaccine was well-tolerated and there were no serious safety events confirmed related to the vaccine.<\/li>\n<li><strong>Storage<\/strong>: The vaccine can be stored, transported and handled at normal refrigerated conditions (2\u00b0C to 8\u00b0C) for at least six months.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/timesofindia.indiatimes.com\/india\/expert-panel-grants-emergency-use-authorisation-for-oxford-vaccine\/articleshow\/80061452.cms\" target=\"_blank\" rel=\"noopener noreferrer\">Article source<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>News:\u00a0The subject expert committee of Central Drugs Standard Control Organization(CDSCO) has recommended COVID-19 vaccine, Covishield for emergency use authorisation. Facts: COVISHIELD:\u00a0The Oxford vaccine \u201cAZD1222\u201d is being called Covishield in India. Serum Institute of India(SII) has entered into a manufacturing partnership with Oxford University and Pharma major AstraZeneca to produce this vaccine in India. Technology: Covishield&hellip; <a class=\"more-link\" href=\"https:\/\/forumias.com\/blog\/expert-panel-grants-emergency-use-authorisation-for-oxford-vaccine\/\">Continue reading <span class=\"screen-reader-text\">Expert panel grants emergency use authorisation for Oxford vaccine<\/span><\/a><\/p>\n","protected":false},"author":61,"featured_media":75267,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":""},"categories":[1351,1310,9],"tags":[1289,1456,1472],"class_list":["post-75190","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-daily-news","category-daily-news-updates","category-public","tag-soc_0","tag-soc_01","tag-vaccine_related_issues","entry"],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/forumias.com\/blog\/wp-content\/uploads\/2021\/01\/Expert-panel-grants-emergency-use-authorisation-for-Oxford-vaccine.jpg?fit=1280%2C720&ssl=1","views":{"total":0,"cached_at":"","cached_date":1704786930},"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/posts\/75190","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/users\/61"}],"replies":[{"embeddable":true,"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/comments?post=75190"}],"version-history":[{"count":0,"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/posts\/75190\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/media\/75267"}],"wp:attachment":[{"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/media?parent=75190"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/categories?post=75190"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/tags?post=75190"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}